Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine

BACKGROUND: The U.S. Centers for Disease Control and Prevention (CDC) recommended a new regimen for treatment of latent tuberculosis (three months of weekly isoniazid and rifapentine) in late 2011. While completion rates of this regimen were reported to be higher than nine months of isoniazid, littl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Infect Dis
Main Authors: McClintock, Adelaide H., Eastment, McKenna, McKinney, Christy M., Pitney, Caroline L., Narita, Masahiro, Park, David R., Dhanireddy, Shireesha, Molnar, Alexandra
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310079/
https://ncbi.nlm.nih.gov/pubmed/28196479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2245-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki